What is the Supriya Lifescience Ltd share price today?

The share price of NSE:SUPRIYA-EQ on 01 Oct 2026 (as of 15:05:00 IST) is ₹929.2.

What is the NSE:SUPRIYA-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SUPRIYA-EQ 52 week high low range shows a high of ₹1085 and a low of ₹545.5.

What is the Supriya Lifescience Ltd market cap?

As on 01 Oct 2026, Supriya Lifescience Ltd market cap is ₹76527100000.

What is the shareholding pattern of Supriya Lifescience Ltd Stock?

The shareholding pattern of Supriya Lifescience Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 68.3% Foreign Institutional Investors (FII): 6.18% Domestic Institutional Investors (DII): 4.01% Mutual Funds: 1.29% Retail & Others: 20.22% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Supriya Lifescience Ltd?

The Price-to-Earnings (PE) ratio of Supriya Lifescience Ltd is 38.5772, and the Price-to-Book (PB) ratio is 3.7973, as on 01 Oct 2026.

Supriya Lifescience Share Price

886.00+13.40 (+1.54%)

+22.60% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+1.54%

1 Week

+2.14%

1 Month

-1.63%

3 Month

+6.91%

6 Month

+42.95%

YTD

+17.90%

1 Year

+22.60%

5 Year

10 Year

Max

+110.45%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

867.10

839.90

740.45

618.00

545.50

High

892.00

1019.80

1085.00

About

Supriya Lifescience Limited is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

SUPRIYANSE

LTP

1W Low

1W High

Market cap (₹)

1758.8-1.2 (-0.07%)

1725.50

1778

4,22,427Cr

9144.5-281.5 (-2.99%)

8937.50

9431.50

2,39,982Cr

4558.9-123.1 (-2.63%)

4550.40

4682

1,75,196Cr

1123-11.4 (-1.00%)

1107.30

1150.90

1,13,790Cr

2060.1-9.1 (-0.44%)

2007.80

2086

1,09,143Cr

1325.1+13.8 (1.05%)

1300.20

1337.50

1,07,746Cr

1233+3.6 (0.29%)

1196.90

1250.70

1,01,894Cr

2275.5-124.5 (-5.19%)

2268.70

2426.80

97,264Cr

1666.9-40 (-2.34%)

1647.10

1715

96,376Cr

1961.6+26.6 (1.37%)

1925.70

1990.90

89,592Cr

886+18.55 (2.14%)

839.90

892

7,025Cr

Supriya Lifescience Share Price

886.00+13.40 (+1.54%)

+22.60% past 1 Year

Financial overview

Compounded Sales Growth

10 years17%

5 years16%

3 years22%

Last year19%

Compounded Profit Growth

10 years43%

5 years11%

3 years33%

Last year11%

Stock Price CAGR

10 years-

5 years-

3 years54%

1 year23%

Return on Equity

10 years31%

5 years21%

3 years19%

Last year19%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
17%	16%	22%	19%
43%	11%	33%	11%
-	-	54%	23%
31%	21%	19%	19%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

SUPRIYA

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,758.8	₹422427 Cr	34.92	12.07	62.82	₹11479 Cr
9,144.5	₹239982 Cr	82.05	34.04	128.41	₹2568 Cr
4,558.9	₹175196 Cr	80.33	16.72	97.06	₹2163 Cr
1,123	₹113790 Cr	25.21	9.42	62.53	₹5040 Cr
2,060.1	₹109143 Cr	99.82	6.8	29.25	₹889 Cr
1,325.1	₹107746 Cr	31.97	9.77	57.87	₹3879 Cr
1,233	₹101894 Cr	31.62	5.32	63.99	₹4196 Cr
2,275.5	₹97264 Cr	47.62	13.75	71.08	₹1913 Cr
1,666.9	₹96376 Cr	25.96	17.95	96.84	₹3505 Cr
1,961.6	₹89592 Cr	16.2	30.95	154.35	₹5333 Cr
886	₹7025 Cr	35.41	2.99	28.49	₹209 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020
₹190 Cr	₹277 Cr	₹206 Cr	₹200 Cr	₹145 Cr	₹184 Cr	₹186 Cr	₹166 Cr	₹161 Cr	₹158 Cr	₹140 Cr	₹140 Cr	₹132 Cr	₹142 Cr	₹105 Cr	₹112 Cr	₹101 Cr	₹181 Cr	₹117 Cr	₹148 Cr	₹77 Cr	₹132 Cr	₹81 Cr
₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹4 Cr
₹192 Cr	₹280 Cr	₹209 Cr	₹203 Cr	₹148 Cr	₹187 Cr	₹188 Cr	₹169 Cr	₹163 Cr	₹160 Cr	₹143 Cr	₹143 Cr	₹135 Cr	₹144 Cr	₹108 Cr	₹115 Cr	₹104 Cr	₹185 Cr	₹122 Cr	₹151 Cr	₹79 Cr	₹134 Cr	₹85 Cr
₹151 Cr	₹187 Cr	₹141 Cr	₹134 Cr	₹100 Cr	₹123 Cr	₹125 Cr	₹106 Cr	₹103 Cr	₹107 Cr	₹103 Cr	₹112 Cr	₹91 Cr	₹90 Cr	₹94 Cr	₹87 Cr	₹73 Cr	₹109 Cr	₹81 Cr	₹57 Cr	₹64 Cr	₹67 Cr	₹60 Cr
₹50 Cr	₹101 Cr	₹75 Cr	₹75 Cr	₹54 Cr	₹71 Cr	₹68 Cr	₹67 Cr	₹65 Cr	₹58 Cr	₹45 Cr	₹34 Cr	₹47 Cr	₹57 Cr	₹17 Cr	₹31 Cr	₹34 Cr	₹79 Cr	₹44 Cr	₹97 Cr	₹17 Cr	₹69 Cr	₹30 Cr
₹37 L	₹47 L	₹49 L	₹42 L	₹51 L	₹42 L	₹51 L	₹43 L	₹34 L	₹60 L	₹49 L	₹46 L	₹82 L	₹71 L	₹1 Cr	₹78 L	₹58 L	₹1 Cr	₹1 Cr	₹17 Cr	₹97 L	₹1 Cr	₹81 L
₹41 Cr	₹92 Cr	₹67 Cr	₹68 Cr	₹47 Cr	₹64 Cr	₹63 Cr	₹62 Cr	₹60 Cr	₹53 Cr	₹40 Cr	₹30 Cr	₹43 Cr	₹53 Cr	₹13 Cr	₹27 Cr	₹30 Cr	₹75 Cr	₹40 Cr	₹78 Cr	₹14 Cr	₹66 Cr	₹25 Cr
₹24 Cr	₹74 Cr	₹50 Cr	₹50 Cr	₹35 Cr	₹50 Cr	₹47 Cr	₹46 Cr	₹45 Cr	₹37 Cr	₹30 Cr	₹24 Cr	₹29 Cr	₹38 Cr	₹10 Cr	₹17 Cr	₹25 Cr	₹46 Cr	₹40 Cr	₹58 Cr	₹8 Cr	₹49 Cr	₹16 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹25 L	₹25 L	₹5 L
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹0	₹0	₹77 L	₹77 L	₹2 Cr	₹3 Cr	₹0
₹1182 Cr	₹981 Cr	₹799 Cr	₹683 Cr	₹600 Cr	₹254 Cr	₹135 Cr	₹79 Cr	₹40 Cr	₹31 Cr	₹26 Cr	₹33 Cr	₹26 Cr	₹20 Cr	₹18 Cr	₹16 Cr	₹5 Cr	₹90 L
₹1182 Cr	₹981 Cr	₹799 Cr	₹683 Cr	₹600 Cr	₹254 Cr	₹135 Cr	₹79 Cr	₹40 Cr	₹26 Cr	₹20 Cr	₹26 Cr	₹19 Cr	₹13 Cr	₹11 Cr	₹9 Cr	₹5 Cr	₹90 L
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹0	₹0
₹1198 Cr	₹997 Cr	₹815 Cr	₹699 Cr	₹616 Cr	₹269 Cr	₹149 Cr	₹94 Cr	₹55 Cr	₹46 Cr	₹42 Cr	₹37 Cr	₹30 Cr	₹26 Cr	₹22 Cr	₹19 Cr	₹9 Cr	₹95 L
₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹8 Cr	₹35 Cr	₹44 Cr	₹31 Cr	₹17 Cr	₹13 Cr	₹8 Cr	₹6 Cr	₹21 Cr	₹20 Cr	₹23 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹4 Cr	₹3 Cr	₹87 L	-₹21 L	₹1 Cr	₹1 Cr	₹81 L	₹7 Cr
₹31 Cr	₹27 Cr	₹23 Cr	₹14 Cr	₹11 Cr	₹8 Cr	₹8 Cr	₹10 Cr	₹9 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹58 L
₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹22 Cr	₹21 Cr	₹6 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹2 Cr	₹1 Cr	₹80 L	₹6 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹69 L	₹58 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹38 Cr	₹33 Cr	₹29 Cr	₹25 Cr	₹19 Cr	₹31 Cr	₹32 Cr	₹24 Cr	₹45 Cr	₹51 Cr	₹39 Cr	₹23 Cr	₹17 Cr	₹11 Cr	₹9 Cr	₹24 Cr	₹22 Cr	₹30 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹111 Cr	₹75 Cr	₹60 Cr	₹64 Cr	₹49 Cr	₹51 Cr	₹49 Cr	₹44 Cr	₹42 Cr	₹41 Cr	₹50 Cr	₹30 Cr	₹31 Cr	₹24 Cr	₹21 Cr	₹17 Cr	₹13 Cr	₹11 Cr
₹9 Cr	₹11 Cr	₹20 Cr	₹10 Cr	₹23 Cr	₹11 Cr	₹26 Cr	₹8 Cr	₹15 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹56 L
₹0	₹0	₹0	₹17 Cr	₹21 Cr	₹67 Cr	₹77 Cr	₹77 Cr	₹86 Cr	₹95 Cr	₹95 Cr	₹79 Cr	₹47 Cr	₹37 Cr	₹26 Cr	₹0	₹0	₹0
₹2 Cr	₹1 Cr	₹37 L	₹5 Cr	₹7 Cr	₹16 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹77 L	₹1 Cr
₹121 Cr	₹87 Cr	₹80 Cr	₹96 Cr	₹100 Cr	₹146 Cr	₹155 Cr	₹135 Cr	₹146 Cr	₹144 Cr	₹150 Cr	₹115 Cr	₹83 Cr	₹65 Cr	₹50 Cr	₹20 Cr	₹15 Cr	₹13 Cr
₹1357 Cr	₹1117 Cr	₹924 Cr	₹820 Cr	₹735 Cr	₹445 Cr	₹336 Cr	₹253 Cr	₹245 Cr	₹241 Cr	₹231 Cr	₹176 Cr	₹130 Cr	₹101 Cr	₹82 Cr	₹63 Cr	₹46 Cr	₹44 Cr
₹9 Cr	₹4 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹2 Cr	₹92 L	₹54 L	₹54 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹17 Cr	₹21 Cr	₹70 Cr	₹82 Cr	₹90 Cr	₹130 Cr	₹140 Cr	₹129 Cr	₹99 Cr	₹62 Cr	₹45 Cr	₹33 Cr	₹23 Cr	₹21 Cr	₹30 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹799 Cr	₹534 Cr	₹371 Cr	₹306 Cr	₹223 Cr	₹123 Cr	₹114 Cr	₹95 Cr	₹96 Cr	₹98 Cr	₹89 Cr	₹71 Cr	₹53 Cr	₹44 Cr	₹36 Cr	₹32 Cr	₹21 Cr	₹19 Cr
₹110 Cr	₹81 Cr	₹61 Cr	₹45 Cr	₹33 Cr	₹23 Cr	₹16 Cr	₹10 Cr	₹5 Cr	₹9 Cr	₹14 Cr	₹10 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹1 Cr	₹65 L
₹689 Cr	₹453 Cr	₹310 Cr	₹262 Cr	₹190 Cr	₹100 Cr	₹98 Cr	₹85 Cr	₹91 Cr	₹89 Cr	₹75 Cr	₹61 Cr	₹45 Cr	₹39 Cr	₹32 Cr	₹29 Cr	₹20 Cr	₹18 Cr
₹36 Cr	₹148 Cr	₹149 Cr	₹68 Cr	₹43 Cr	₹79 Cr	₹40 Cr	₹35 Cr	₹34 Cr	₹36 Cr	₹25 Cr	₹11 Cr	₹5 Cr	₹32 L	₹39 L	₹42 L	₹98 L	₹1 Cr
₹99 Cr	₹63 Cr	₹64 Cr	₹25 Cr	₹5 L	₹5 L	₹5 L	₹5 L	₹12 L	₹10 L	₹10 L	₹10 L	₹9 L	₹3 L	₹2 L	₹1 L	₹25,000	₹25,000
₹99 Cr	₹63 Cr	₹64 Cr	₹25 Cr	₹5 L	₹5 L	₹5 L	₹5 L	₹12 L	₹10 L	₹10 L	₹10 L	₹9 L	₹3 L	₹2 L	₹1 L	₹25,000	₹25,000
₹2 Cr	₹11 Cr	₹68 L	₹93 L	₹4 Cr	₹1 Cr	₹18 L	₹30 L	₹32 L	₹2 Cr	₹2 Cr	₹33 L	₹1 Cr	₹37 L	₹33 L	₹0	₹0	₹0
₹825 Cr	₹675 Cr	₹523 Cr	₹355 Cr	₹237 Cr	₹180 Cr	₹138 Cr	₹120 Cr	₹126 Cr	₹126 Cr	₹102 Cr	₹73 Cr	₹52 Cr	₹39 Cr	₹33 Cr	₹30 Cr	₹21 Cr	₹19 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹160 Cr	₹118 Cr	₹85 Cr	₹116 Cr	₹92 Cr	₹72 Cr	₹49 Cr	₹31 Cr	₹32 Cr	₹38 Cr	₹53 Cr	₹39 Cr	₹30 Cr	₹30 Cr	₹24 Cr	₹15 Cr	₹9 Cr	₹7 Cr
₹219 Cr	₹134 Cr	₹112 Cr	₹85 Cr	₹115 Cr	₹74 Cr	₹52 Cr	₹60 Cr	₹53 Cr	₹50 Cr	₹42 Cr	₹35 Cr	₹28 Cr	₹18 Cr	₹16 Cr	₹12 Cr	₹8 Cr	₹10 Cr
₹79 Cr	₹79 Cr	₹75 Cr	₹158 Cr	₹228 Cr	₹89 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹93 L
₹9 Cr	₹11 Cr	₹16 Cr	₹17 Cr	₹13 Cr	₹4 Cr	₹1 Cr	₹32 L	₹63 L	₹1 Cr	₹64 L	₹1 Cr	₹56 L	₹66 L	₹17 L	₹41 L	₹19 L	₹12 L
₹65 Cr	₹99 Cr	₹113 Cr	₹90 Cr	₹49 Cr	₹26 Cr	₹93 Cr	₹40 Cr	₹31 Cr	₹20 Cr	₹26 Cr	₹23 Cr	₹16 Cr	₹10 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹7 Cr
₹532 Cr	₹442 Cr	₹400 Cr	₹465 Cr	₹498 Cr	₹265 Cr	₹198 Cr	₹133 Cr	₹120 Cr	₹115 Cr	₹129 Cr	₹103 Cr	₹78 Cr	₹62 Cr	₹49 Cr	₹33 Cr	₹25 Cr	₹25 Cr
₹411 Cr	₹355 Cr	₹321 Cr	₹369 Cr	₹398 Cr	₹119 Cr	₹43 Cr	-₹2 Cr	-₹26 Cr	-₹29 Cr	-₹21 Cr	-₹12 Cr	-₹4 Cr	-₹3 Cr	-₹1 Cr	₹13 Cr	₹10 Cr	₹12 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 L	₹3 L	₹4 L
₹1357 Cr	₹1117 Cr	₹924 Cr	₹820 Cr	₹735 Cr	₹445 Cr	₹336 Cr	₹253 Cr	₹245 Cr	₹241 Cr	₹231 Cr	₹176 Cr	₹130 Cr	₹101 Cr	₹82 Cr	₹63 Cr	₹46 Cr	₹44 Cr
₹149	₹124	₹101	₹87	₹76	₹37	₹102	₹64	₹37	₹28	₹24	₹64	₹49	₹38	₹43	₹378	₹221	₹182
₹149	₹124	₹101	₹87	₹76	₹37	₹20	₹13	₹7	₹6	₹5	₹4	₹3	₹2	₹0	₹1	₹1	₹1

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009
₹275 Cr	₹248 Cr	₹166 Cr	₹123 Cr	₹207 Cr	₹167 Cr	₹96 Cr	₹57 Cr	₹14 Cr	₹8 Cr	₹8 Cr	₹10 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0
₹20 Cr	₹14 Cr	₹2 Cr	₹5 Cr	₹7 Cr	₹5 Cr	₹10 Cr	₹13 Cr	₹16 Cr	₹16 Cr	₹13 Cr	₹9 Cr	₹8 Cr	₹0	₹0	₹0	₹0	₹0
-₹47 Cr	-₹38 Cr	-₹17 Cr	-₹34 Cr	-₹104 Cr	-₹67 Cr	₹37 Cr	-₹7 Cr	₹80 L	₹3 Cr	-₹7 Cr	-₹25 Cr	-₹10 Cr	₹0	₹0	₹0	₹0	₹0
₹247 Cr	₹224 Cr	₹151 Cr	₹94 Cr	₹110 Cr	₹106 Cr	₹143 Cr	₹63 Cr	₹31 Cr	₹27 Cr	₹15 Cr	-₹6 Cr	₹6 Cr	₹0	₹0	₹0	₹0	₹0
₹186 Cr	₹165 Cr	₹113 Cr	₹64 Cr	₹49 Cr	₹76 Cr	₹116 Cr	₹49 Cr	₹28 Cr	₹27 Cr	₹14 Cr	-₹6 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0
-₹176 Cr	-₹152 Cr	-₹174 Cr	-₹124 Cr	-₹60 Cr	-₹47 Cr	-₹25 Cr	₹5 Cr	-₹5 Cr	-₹27 Cr	-₹33 Cr	-₹23 Cr	-₹14 Cr	₹0	₹0	₹0	₹0	₹0
-₹10 Cr	-₹8 Cr	-₹22 Cr	-₹10 Cr	₹150 Cr	-₹15 Cr	-₹29 Cr	-₹50 Cr	-₹20 Cr	-₹2 Cr	₹21 Cr	₹30 Cr	₹10 Cr	₹0	₹0	₹0	₹0	₹0
-₹29 L	₹4 Cr	-₹83 Cr	-₹70 Cr	₹139 Cr	₹15 Cr	₹62 Cr	₹4 Cr	₹3 Cr	-₹2 Cr	₹2 Cr	₹75 L	₹1 Cr	₹0	₹0	₹0	₹0	₹0
₹79 Cr	₹75 Cr	₹158 Cr	₹228 Cr	₹89 Cr	₹75 Cr	₹12 Cr	₹9 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0
₹79 Cr	₹79 Cr	₹75 Cr	₹158 Cr	₹228 Cr	₹89 Cr	₹75 Cr	₹12 Cr	₹9 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹0	₹0	₹0	₹0	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Supriya Lifescience Share Price

886.00+13.40 (+1.54%)

+22.60% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Supriya Lifescience Share Price

886.00+13.40 (+1.54%)

+22.60% past 1 Year

Shareholding summary

Promoters

68.3%

FII

6.45%

DII

4.19%

1.28%

Others

19.78%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
68.30%	68.30%	68.30%	68.30%	68.30%	68.30%
6.45%	6.18%	5.16%	5.19%	5.46%	6.78%
4.19%	4.01%	4.37%	4.33%	4.54%	4.18%
1.28%	1.29%	1.33%	0.67%	0.68%	0.68%
19.78%	20.22%	20.84%	21.51%	21.02%	20.06%

Bulk & block deals

Name

Graviton Research Capital Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
22 Nov 2024	Sell	45.93 Cr	₹785.02	5.85 L	Bulk	0.726948	NSE
22 Nov 2024	Purchase	45.92 Cr	₹784.79	5.85 L	Bulk	0.726948	NSE
12 Aug 2024	Sell	32.16 Cr	₹488.61	6.58 L	Bulk	0.81792	NSE
12 Aug 2024	Purchase	32.16 Cr	₹488.59	6.58 L	Bulk	0.81792	NSE
08 Feb 2024	Sell	21.49 Cr	₹342.32	6.28 L	Bulk	0.780034	NSE
08 Feb 2024	Purchase	21.48 Cr	₹342.21	6.28 L	Bulk	0.780034	NSE
26 Dec 2023	Sell	14.27 Cr	₹312.40	4.57 L	Bulk	0.567407	NSE
26 Dec 2023	Purchase	14.26 Cr	₹312.26	4.57 L	Bulk	0.567407	NSE
12 May 2023	Purchase	10.01 Cr	₹248.38	4.03 L	Bulk	0.500911	NSE
12 May 2023	Sell	10.02 Cr	₹248.48	4.03 L	Bulk	0.500911	NSE

Insider trading & SAST

Client name

Shivani Satish Wagh

Shivani Satish Wagh & Pacs

Dr Saloni Satish Wagh

Shivani Satish Wagh

Saloni Satish Wagh

Shivani Satish Wagh

Dr Satish Wagh

Satish Waman Wagh

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
05 Mar 2024	Other	Acquisition	0.09	—	0	—	73.12 K	26 Feb 2024	-	—	SAST	10(6)	—
05 Mar 2024	Promoter	Disposal	0.09	68.3	0	—	73.12 K	26 Feb 2024	Off Market / Inter se transfer	5,49,67,715	SAST	29(2)	—
05 Mar 2024	Promoter	Acquisition	0.09	68.3	0	—	73.12 K	26 Feb 2024	Off Market / Inter se transfer	5,49,67,715	SAST	29(1)	—
04 Mar 2024	Promoter	Disposal	0.09	68.3	0	—	73.12 K	26 Feb 2024	Off Market / Inter se transfer	5,49,67,715	SAST	29(2)	—
04 Mar 2024	Promoter	Acquisition	0.09	68.3	0	—	73.12 K	26 Feb 2024	Off Market / Inter se transfer	5,49,67,715	SAST	29(2)	—
28 Feb 2024	Promoter Group	Disposal	0.090858	0.13	0	—	73.12 K	26 Feb 2024	Gift	1,02,375	Insider Trading	—	Equity Shares
28 Feb 2024	Promoter Group	Acquisition	0.090858	0.13	0	—	73.12 K	26 Feb 2024	Gift	1,02,375	Insider Trading	—	Equity Shares
04 Jan 2024	Promoter	Acquisition	0.09	—	0	—	73.12 K	27 Dec 2023	—	—	SAST	10(1)(a)	—
04 Apr 2023	Promoter	Acquisition	0.01	67.64	0	—	13 K	31 Mar 2023	Market	5,44,41,205	SAST	29(2)	—
03 Apr 2023	Promoter	Acquisition	0.016153	67.64	24.73 L	₹190.22	13 K	31 Mar 2023	Market Purchase	5,44,41,205	Insider Trading	—	Equity Shares

Supriya Lifescience Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Supriya Lifescience Share Price

Supriya Lifescience Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Supriya Lifescience Share Price

Supriya Lifescience Share Price

Oscillators

Moving averages

Supriya Lifescience Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Supriya Lifescience Share Price

Corporate Actions

Company details

Supriya Lifescience Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Supriya Lifescience Share Price

News

Court Allows Provisional Release Of Supriya Lifescience Consignment

Supriya Lifescience to host analyst and investor meet on September 17

Supriya Lifescience GM held in judicial custody amid Customs NDPS probe

Supriya Lifescience sets over Rs 1000 crore revenue goal by FY27

Supriya Lifescience reports Profit after tax of 74.23 Crores, in the March 2026 quarter

Supriya Lifescience Q4 EBITDA rises sharply year-on-year amid softer margins

Supriya Lifescience Q4 profit and revenue surge strongly on yearly basis

Supriya Lifescience informs about updates

Supriya Lifescience gets EIR for manufacturing facility at Lote

Supriya Lifescience USFDA Inspection Concludes with One Minor VAI at Manufacturing Facility.

Supriya Lifescience USFDA Inspection Concludes with One Minor VAI at Manufacturing Facility.

Investor Madhu Kela Increases Stake by 0.4% in Supriya Lifescience in Q4.

Supriya Lifescience informs about transcript of earnings Call

Supriya Lifescience Q3 FY26 Results: 11% Revenue Growth, 9% EBITDA Rise, Margins Dip Slightly.

Supriya Lifescience Q3 FY26 Results: Net Profit Up 6% YoY to Rs 49.70 Crores, Revenue Rises 10.8% to Rs 206 Crores.

Supriya Lifescience reports Profit after tax of 49.67 Crores, in the December 2025 quarter

Supriya Lifescience moves higher on aiming up to Rs 1,600 crore revenue in next three years

Supriya Lifescience aims up to Rs 1,600 crore revenue in next three years

Supriya Lifescience guides for Q2FY26 growth, robust EBITDA margin, increased API focus, and export expansion

Supriya Lifescience reports Profit after tax of 50.43 Crores, in the September 2025 quarter

Supriya Lifescience Ltd Share Price Today

Supriya Lifescience Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator